Evidence map›Paper›PMID 32976535›Full record

ArticlePloS one2020

Tumor budding score predicts lymph node status in oral tongue squamous cell carcinoma and should be included in the pathology report.

Inger-Heidi Bjerkli, Helene Laurvik, Elisabeth Sivy Nginamau, Tine M Søland, Daniela Costea, Håkon Hov, Lars Uhlin-Hansen, Elin Hadler-Olsen, Sonja E Steigen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Tumor Budding and Poor Prognosis in Oral Cancer: A Systematic Review and Meta-Analysis.Asian Pacific journal of cancer prevention : APJCP · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Inger-Heidi BjerkliDepartment of Otorhinolaryngology, University Hospital of North Norway, Tromsø, Norway.ORCID 0000-0002-5059-5124
Helene LaurvikDepartment of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
Elisabeth Sivy NginamauDepartment of Pathology, Haukeland University Hospital, Bergen, Norway.
Tine M SølandDepartment of Pathology, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
Daniela CosteaDepartment of Pathology, Haukeland University Hospital, Bergen, Norway.
Håkon HovDepartment of Pathology, St. Olavs Hospital, Trondheim, Norway.
Lars Uhlin-HansenDepartment of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.
Elin Hadler-OlsenDepartment of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.
Sonja E SteigenDepartment of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.ORCID 0000-0001-8376-2489
University Hospital of North Norway · NOHaukeland University Hospital · NOOslo University Hospital · NONorthern Norway Regional Health Authority · NONorwegian University of Science and Technology · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe majority of oral cavity cancers arise in the oral tongue. The aim of this study was to evaluate the prognostic value of tumor budding in oral tongue squamous cell carcinoma, both as a separate variable and in combination with depth of invasion. We also assessed the prognostic impact of the 8th edition of the American Joint Committee on Cancer's TNM classification (TNM8), where depth of invasion (DOI) supplements diameter in the tumor size (T) categorization.

methodsPatients diagnosed with primary oral tongue squamous cell carcinoma were evaluated retrospectively. Spearman bivariate correlation analyses with bootstrapping were used to identify correlation between variables. Prognostic value of clinical and histopathological variables was assessed by Log rank and Cox regression analyses with bootstrapping using 5-year disease specific survival as outcome. The significance level for the hypothesis test was 0.05.

resultsOne-hundred and fifty patients had available material for microscopic evaluation on Hematoxylin and Eosin-stained slides and were included in the analyses. Reclassification of tumors according to TNM8 caused a shift towards a higher T status compared to the previous classification. The tumor budding score was associated with lymph node metastases where 23% of the patients with low-budding tumors had lymph node metastases, compared with 43% of those with high-budding tumors. T-status, lymph node status, tumor budding, depth of invasion, and the combined tumor budding/depth of invasion score were all significantly associated with survival in univariate analyses. In multivariate analyses only N-status was an independent prognosticator of survival.

conclusionReclassification according to TNM8 shifted many tumors to a higher T-status, and also increased the prognostic value of the T-status. This supports the implementation of depth of invasion to the T-categorization in TNM8. Tumor budding correlated with lymph node metastases and survival. Therefore, information on tumor budding can aid clinicians in treatment planning and should be included in pathology reports of oral tongue squamous cell carcinomas.

Indexed as

AgedAged, 80 and overCarcinoma, Squamous CellFemaleHumansLymphatic MetastasisLymph NodesMaleMiddle AgedNeoplasm StagingPractice Guidelines as TopicTongue Neoplasms

Identifiers

PMID32976535
PMCPMC7518591
OpenAlexW3088267570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.